BOC Sciences - Products
London
BOC Sciences provides various research (bio)chemicals: inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities, metabolites, APIs, natural compounds, ADCs, and chiral compounds.
| Product | Description | |
|---|---|---|
| Ularitide TFA | Urodilatin is a hormone that is involved in regulating blood pressure and the excretion of water and sodium from the kidneys. Group: Pharmaceutical. Alternative Names: Urodilatin human trifluoroacetate salt. Pack Sizes: 5 mg. Product ID: B1370-449812. Molecular formula: C145H234N52O44S3 (free base). Mole weight: 3505.93 (free base). Custom synthesis is available. Send your inquiries for more information. |  London |
| Ulinastatin | Ulinastatin is an acid-resistant protease inhibitor derived from human urine, acting as a potent anti-inflammatory agent. It was shown to inhibit the activities of a variety of enzymes, including trypsin, chymotrypsin, thrombin, kallikrein, plasmin, elastase, cathepsin, lipase, hyaluronidase, factors IXa, Xa, XIa, and XlIa, and polymorphonuclear leukocyte elastase. Group: Pharmaceutical. Alternative Names: Urinastatin; 2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)-. CAS No. 80449-31-6. Pack Sizes: 1 g. Product ID: B2693-135299. Molecular formula: C13H16O3. Mole weight: 220.26. Custom synthesis is available. Send your inquiries for more information. | London |
| Ulipristal | Ulipristal is a selective SPRM for emergency contraception after an unprotected intercourse or contraceptive failure. Group: Pharmaceutical. Alternative Names: CDB-2914; CDB2914; CDB 2914; Ulipristal; VA-2914; VA 2914; VA2914; PGL-4001; PGL 4001; PGL4001. CAS No. 159811-51-5. Pack Sizes: 1 g. Product ID: B2692-264332. Molecular formula: C28H35NO3. Mole weight: 433.58. Custom synthesis is available. Send your inquiries for more information. | London |
| Ulipristal Acetate | Ulipristal Acetate is an orally bioactive and selective progesterone receptor modulator (SPRM) used for emergency contraception and uterine fibroid. It binds to the progesterone receptor (PR) to inhibit PR-mediated gene expression. Uses: Emergency contraception and uterine fibroid. Group: Pharmaceutical. Alternative Names: Ella; EllaOne; Ulipristal (acetate); CDB-2914; [(8S,11R,13S,14S,17R)-17-acetyl-11-[4-(dimethylamino)phenyl]-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate; CDB 2914; CDB2914. CAS No. 126784-99-4. Pack Sizes: 100 mg. Product ID: B0084-474444. Molecular formula: C30H37NO4. Mole weight: 475.62. Custom synthesis is available. Send your inquiries for more information. | London |
| Ulixertinib | Ulixertinib, also known as VRT752271, is an inhibitor of ERK protein kinase. Group: Pharmaceutical. Alternative Names: (S)-4-(5-chloro-2-(isopropylamino)pyridin-4-yl)-N-(1-(3-chlorophenyl)-2-hydroxyethyl)-1H-pyrrole-2-carboxamide; BVD-523; BVD 523; BVD523; VRT752271; VRT752271; VRT 752271; Ulixertinib. CAS No. 869886-67-9. Pack Sizes: 500 mg. Product ID: B2693-460061. Molecular formula: C21H22Cl2N4O2. Mole weight: 433.333. Custom synthesis is available. Send your inquiries for more information. | London |
| Umbralisib | Umbralisib is an orally bioavailable and selective PI3K delta inhibitor that targets delta isoform with nanomolar potency, which is approximately 1000-fold selective over alpha isoform, >30-50 fold over beta isoform and >15-50 fold over gamma isoforms. Umbralisib is developed for lymphoma therapy. Group: Pharmaceutical. Alternative Names: TGR-1202; TGR 1202; TGR1202; RP5264; 2-[(1S)-1-[4-amino-3-(3-fluoro-4-propan-2-yloxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-6-fluoro-3-(3-fluorophenyl)chromen-4-one. CAS No. 1532533-67-7. Pack Sizes: 1 g. Product ID: B0084-474608. Molecular formula: C31H24F3N5O3. Mole weight: 571.5. Custom synthesis is available. Send your inquiries for more information. | London |
| Umeclidinium bromide | Umeclidinium bromide(GSK573719A) is a muscarinic receptor antagonist which is useful in treatment of chronic obstructive pulmonary disease (COPD). Group: Pharmaceutical. Alternative Names: GSK-573719, GSK573719, GSK 573719, GSK-573719A, GSK573719A, GSK 573719A, Incruse Ellipta, Umeclidinium bromide. CAS No. 869113-09-7. Pack Sizes: 25 mg. Product ID: B0084-460044. Molecular formula: C29H34BrNO2. Mole weight: 508.5. Custom synthesis is available. Send your inquiries for more information. | London |
| UNC-0638 | UNC0638 is an inhibitor of G9a and GLP with excellent potency and selectivity over a wide range of epigenetic and non-epigenetic targets. UNC0638 treatment of a variety of cell lines resulted in lower global H3K9me2 levels, equivalent to levels observed for small hairpin RNA knockdown of G9a and GLP with the functional potency of UNC0638 being well separated from its toxicity. UNC0638 markedly reduced the clonogenicity of MCF7 cells, reduced the abundance of H3K9me2 marks at promoters of known G9a-regulated endogenous genes and disproportionately affected several genomic loci encoding microRNAs. Group: Pharmaceutical. Alternative Names: UNC0638, UNC-0638, UNC 0638. CAS No. 1255580-76-7. Pack Sizes: 25 mg. Product ID: B2693-456088. Molecular formula: C30H47N5O2. Mole weight: 509.739. Custom synthesis is available. Send your inquiries for more information. | London |
| UNC1215 | UNC1215 is a potent, selective antagonist of L3MBTL3 with cellular activity. UNC1215 has an IC50 of 20 nM and > 100-fold selectivity over 13 HMTs and selected representatives of kinases, ion channels, 7TMs, and other epigenetic proteins. Group: Pharmaceutical. Alternative Names: UNC1215, UNC-1215, UNC 1215; (2-(phenylamino)-1,4-phenylene)bis((4-(pyrrolidin-1-yl)piperidin-1-yl)methanone). CAS No. 1415800-43-9. Pack Sizes: 300 mg. Product ID: B0084-462614. Molecular formula: C32H43N5O2. Mole weight: 529.729. Custom synthesis is available. Send your inquiries for more information. | London |
| UNC-1999 | UNC1999, the first orally bioavailable inhibitor that has high in vitro potency for wildtype and mutant EZH2 as well as EZH1. UNC1999 was highly selective for EZH2 and EZH1 over a broad range of epigenetic and non-epigenetic targets. UNC1999 was orally bioavailable in mice, making this inhibitor a valuable tool for investigating the role of EZH2 and EZH1 in chronic animal studies. UNC-1999 represents a useful tools for the biomedical community to investigate the role of EZH2 and EZH1 in health and disease. Group: Pharmaceutical. Alternative Names: UNC1999; UNC 1999; UNC-1999. CAS No. 1431612-23-5. Pack Sizes: 25 mg. Product ID: B2693-462615. Molecular formula: C33H43N7O2. Mole weight: 569.754. Custom synthesis is available. Send your inquiries for more information. | London |
| UNC-2025 | UNC-2025 is a novel potent and highly orally bioavailable Mer/FLT3 dual inhibitor, capable of inhibiting Mer phosphorylation in vivo, following oral dosing as demonstrated by pharmaco-dynamic (PD) studies examining phospho-Mer in leukemic blasts from mouse bone marrow. Kinome profiling versus more than 300 kinases in vitro and cellular selectivity assessments demonstrate that UNC-2025 has similar subnanomolar activity against Flt3, an additional important target in acute myelogenous leukemia (AML), with pharmacologically useful selectivity versus other kinases examined. Group: Pharmaceutical. Alternative Names: Cyclohexanol, 4-[2-(butylamino)-5-[4-[(4-methyl-1-piperazinyl)methyl]phenyl]-7H-pyrrolo[2,3-d]pyrimidin-7-yl]-, trans-; trans-4-[2-(Butylamino)-5-[4-[(4-methyl-1-piperazinyl)methyl]phenyl]-7H-pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexanol; MRX 6313; UNC 2025; UNC2025. CAS No. 1429881-91-3. Pack Sizes: 100 mg. Product ID: B2693-462616. Molecular formula: C28H40N6O. Mole weight: 476.66. Custom synthesis is available. Send your inquiries for more information. | London |
| UNC-2025 hydrochloride | UNC-2025 hydrochloride is the hydrochloride salt of UNC-2025, which is the Mer/FLT3 dual inhibitor. Group: Pharmaceutical. Alternative Names: UNC-2025 hydrochloride; UNC 2025 hydrochloride; UNC2025 hydrochloride; (1r,4r)-4-(2-(butylamino)-5-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexanol hydrochloride. CAS No. 2070015-17-5. Pack Sizes: 300 mg. Product ID: B0084-053987. Molecular formula: C28H41ClN6O. Mole weight: 513.12. Custom synthesis is available. Send your inquiries for more information. | London |
| UNC2250 | UNC2250 is a potent and selective Mer Kinase inhibitor. When applied to live cells, UNC2250 inhibited steady-state phosphorylation of endogenous Mer with an IC50 of 9.8 nM and blocked ligand-stimulated activation of a chimeric EGFR-Mer protein. Treatment with UNC2250 also resulted in decreased colony-forming potential in rhabdoid and NSCLC tumor cells. The results provide a rationale for further investigation of UNC2250 for therapeutic application in patients with cancer. Group: Pharmaceutical. Alternative Names: UNC-2250; UNC 2250. CAS No. 1493694-70-4. Pack Sizes: 50 mg. Product ID: B2693-462617. Molecular formula: C24H36N6O2. Mole weight: 440.58. Custom synthesis is available. Send your inquiries for more information. | London |
| UNC 3230 | UNC 3230 is a potent and selective PIP5K1C inhibitor (IC50 = 41 nM), displaying selectivity for PIP5K1C over PIP5K1A, the PI 3-kinase family and a panel of other kinases. UNC 3230 decreases PIP2 levels and LPA-induced calcium signaling in dorsal root ganglia (DRG) neurons in vitro. UNC 3230 exhibits antinociceptive effects in mouse models of chronic pain. Group: Pharmaceutical. Alternative Names: UNC3230; UNC-3230; UNC 3230; 5-[(Cyclohexylcarbonyl)amino]-2-(phenylamino)-thiazolecarboxamide. CAS No. 1031602-63-7. Pack Sizes: 100 mg. Product ID: B2693-170513. Molecular formula: C17H20N4O2S. Mole weight: 344.43. Custom synthesis is available. Send your inquiries for more information. | London |
| Uncargenin C | Uncargenin C isolated from the leaves of Turpinia arguta. Group: Pharmaceutical. Alternative Names: Uncargenin C; 152243-70-4; MCULE-9269495116; NCGC00385553-01. CAS No. 152243-70-4. Pack Sizes: 1 mg. Product ID: NP6757. Molecular formula: C30H48O5. Mole weight: 488.7. Custom synthesis is available. Send your inquiries for more information. | London |
| Uncarine A | Uncarine A is an alkaloid isolated from the leaves of Uncaria hirsuta. Group: Pharmaceutical. Alternative Names: Isoformosanine; methyl (1R,4aS,5aS,6S,10aR)-1-methyl-2'-oxospiro[1,4a,5,5a,7,8,10,10a-octahydropyrano[3,4-f]indolizine-6,3'-1H-indole]-4-carboxylate. CAS No. 6899-73-6. Pack Sizes: 1 mg. Product ID: NP0849. Molecular formula: C21H24N2O4. Mole weight: 368.433. Custom synthesis is available. Send your inquiries for more information. | London |
| Uncinatone | Uncinatone is a natural diterpenoid found in the roots of Clerodendrum bungei Steud. Uncinatone shows inhibition of lipopolysaccharide-induced nitric oxide production and inhibitory activity against complement system. Group: Pharmaceutical. Alternative Names: cis-1,8,9,11b-Tetrahydro-7,11-dihydroxy-3,4,9,11b-tetramethylphenanthro[3,2-b]furan-6(2H)-one. CAS No. 99624-92-7. Pack Sizes: 5 mg. Product ID: NP6610. Molecular formula: C20H22O4. Mole weight: 326.39. Custom synthesis is available. Send your inquiries for more information. | London |
| Undecylenamide DEA | Undecylenamide DEA. Group: Pharmaceutical. Alternative Names: Undecylenoyl diethanolamide; undecylenic acid diethanolamide; Diethanolamine undecylenate; 10-Undecylenic acid diethanolamide. CAS No. 60239-68-1. Pack Sizes: 100 mg. Product ID: B1370-144836. Molecular formula: C15H29NO3. Mole weight: 271.4. Custom synthesis is available. Send your inquiries for more information. | London |
| Uniconazole | Uniconazole is a plant growth hormone that inhibits cytochrome P450 707As, resulting in a suppression of gibberellin production. Uses: Fungicides, industrial. Group: Pharmaceutical. Alternative Names: 1H-1,2,4-Triazole-1-ethanol, β-[(4-chlorophenyl)methylene]-α-(1,1-dimethylethyl)-, (βE)-; (βE)-β-[(4-Chlorophenyl)methylene]-α-(1,1-dimethylethyl)-1H-1,2,4-triazole-1-ethanol; 1H-1,2,4-Triazole-1-ethanol, β-[(4-chlorophenyl)methylene]-α-(1,1-dimethylethyl)-, (E)-(±)-; (E)-1-(4-Chlorophenyl)-4,4-dimethyl-2-(1,2,4-triazol-1-yl)-1-penten-3-ol; 1H-1,2,4-Triazole-1-ethanol, β-[(4-chlorophenyl)methylene]-α-(1,1-dimethylethyl)-, (E)-; M 13144; Majic; Majic S 3307D; Pentefenzol; Prunit; S 07; S 327D; S 3307; S 3307D; Sumagic; Sumiseven; XE 1019; XE 1019D. CAS No. 83657-22-1. Pack Sizes: 25 g. Product ID: B0084-078170. Molecular formula: C15H18ClN3O. Mole weight: 291.77. Custom synthesis is available. Send your inquiries for more information. | London |
| Unithiol | Unithiol is a chelating agent used as an antidote against for the treatment of heavy metals and metalloid intoxication. It can also be used for animals. Group: Pharmaceutical. Alternative Names: DMPS. CAS No. 4076-2-2. Pack Sizes: 1mg;1g;10g. Product ID: B0046-463796. Molecular formula: C3H7O3S3Na. Mole weight: 210.27. Custom synthesis is available. Send your inquiries for more information. | London |
| Unoprostone isopropyl ester | Unoprostone isopropyl ester is the prodrug of unoprostone, an analog of prostaglandin F2α (PGF2α). Unoprostone isopropyl ester, under the brand name Rescula, have been approved for the treatment of ocular hypertension. Group: Pharmaceutical. Alternative Names: 13,14-dihydro-15-keto-20-ethyl Prostaglandin F2α isopropyl ester; Rescula. CAS No. 120373-24-2. Pack Sizes: 1mg;1g;10g. Product ID: 120373-24-2. Molecular formula: C25H44O5. Mole weight: 424.6. Custom synthesis is available. Send your inquiries for more information. | London |
| Upadacitinib | Upadacitinib is a selective JAK inhibitor under the development of AbbVie.ABT-494 is nearly 74 fold selective for Jak1 over Jak2 in cellular assays dependent on specific, relevant cytokines. Preliminary evidence suggests that ABT-494 may spare Jak2 and Jak3 dependent signaling compared to tofacitinib. Phase II for the treatment of Atopic dermatitis and Crohn's disease, Phase III for the treatment of Rheumatoid arthritis and Ulcerative colitis was on-going. Uses: Rheumatoid arthritis; ulcerative colitis;atopic dermatitis; crohn's disease. Group: Pharmaceutical. Alternative Names: UNII-4RA0KN46E0;ABT494;(3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide. CAS No. 1310726-60-3. Pack Sizes: 5 mg. Product ID: B0084-475295. Molecular formula: C17H19F3N6O. Mole weight: 380.37. Custom synthesis is available. Send your inquiries for more information. | London |
| Uprosertib | Uprosertib, also known as GSK2141795 and GSK795, is an orally bioavailable inhibitor of the serine/threonine protein kinase Akt (protein kinase B) with potential antineoplastic activity. Akt inhibitor GSK2141795 binds to and inhibits the activity of Akt, which may result in inhibition of the PI3K/Akt signaling pathway and tumor cell proliferation and the induction of tumor cell apoptosis. Activation of the PI3K/Akt signaling pathway is frequently associated with tumorigenesis and dysregulated PI3K/Akt signaling may contribute to tumor resistance to a variety of antineoplastic agents. Group: Pharmaceutical. Alternative Names: GSK-2141795; GSK2141795; GSK 2141795; GSK795; GSK-795; GSK 795. Uprosertib. CAS No. 1047634-65-0. Pack Sizes: 25 mg. Product ID: B0084-462537. Molecular formula: C18H16Cl2F2N4O2. Mole weight: 429.25. Custom synthesis is available. Send your inquiries for more information. | London |
| Uracil | Uracil is one of the four nucleobases in the nucleic acid of RNA, and can be used for drug delivery and as a pharmaceutical. Group: Pharmaceutical. Alternative Names: Cytarabine Impurity D; Pyrimidin-2,4(1H,3H)-dione; 2,4(1H,3H)-Pyrimidinedione; 2,4-Dioxopyrimidine; 2,4-Pyrimidinedione; Pirod; Pyrod; Fluorouracil Impurity C; 1,2,3,4-Tetrahydropyrimidine-2,4-dione; 2,4-Dihydroxypyrimidine; 2,4-Pyrimidinediol; 4-Hydroxyuracil; Hybar X; NSC 3970; Lamivudine EP Impurity F; Fluorouracil EP Impurity C; Cytarabine EP Impurity D. CAS No. 66-22-8. Pack Sizes: 1000 g. Product ID: NP0505. Molecular formula: C4H4N2O2. Mole weight: 112.09. Custom synthesis is available. Send your inquiries for more information. | London |
| Uracil-m7GpppAmpG ammonium | Uracil-m7GpppAmpG ammonium is a cap analog that can be used for mRNA synthesis. Group: Pharmaceutical. Alternative Names: Uracil-m7GpppAmpG 100mM ammonium. Pack Sizes: 100 uL. Product ID: B1370-076752. Molecular formula: C31H42N12O25P4.xNH3. Custom synthesis is available. Send your inquiries for more information. | London |
| URB937 | URB937 is a potent, peripheral fatty acid amide hydrolase (FAAH) inhibitor with IC50 value of 26.8 nM. It was shown to reduce prostaglandin E2-induced bladder overactivity and hyperactivity of bladder mechano-afferent nerve fibers in rats. Group: Pharmaceutical. Alternative Names: URB-937; URB 937; 3'-carbamoyl-6-hydroxybiphenyl-3-yl cyclohexylcarbamate; cyclohexylcarbamic acid 3'-carbamoyl-6-hydroxybiphenyl-3-yl ester. CAS No. 1357160-72-5. Pack Sizes: 100 mg. Product ID: B1370-008861. Molecular formula: C20H22N2O4. Mole weight: 354.4. Custom synthesis is available. Send your inquiries for more information. | London |
| Urea,N-(4-ethoxyphenyl)- | N-(4-ethoxyphenyl)-Urea is an artificial sweetener about 250 times sweeter than sucrose, which is prohibited by FDA from use in human food for its carcinogenic property. Uses: Artificial sweetener. Group: Pharmaceutical. Alternative Names: Dulcin; 1-(4-Ethoxyphenyl)urea; N-(4-Ethoxyphenyl)urea; (4-ethoxyphenyl)urea; P-Ethoxyphenylurea. CAS No. 150-69-6. Pack Sizes: 10 g. Product ID: B0001-167332. Molecular formula: C9H12N2O2. Mole weight: 180.23. Custom synthesis is available. Send your inquiries for more information. | London |
| Uridine 5'-diphosphate disodium salt | UDP disodium salt is an endogenous P2Y receptor agonist which preferentially activates P2Y6. It also acts as a competitive antagonist at P2Y14 receptors. Group: Pharmaceutical. Alternative Names: UDP-Na2; UDP disodium salt; Uridine 5'-diphosphoric acid disodium salt; Uridine 5'-(Trihydrogen diphosphate) Disodium Salt. CAS No. 27821-45-0. Pack Sizes: 10 g. Product ID: B2706-011191. Molecular formula: C9H12N2Na2O12P2. Mole weight: 448.12. Custom synthesis is available. Send your inquiries for more information. | London |
| Uridine 5-diphosphogalactose disodium salt | Uridine 5-diphosphogalactose disodium salt is an indispensable compound in the biomedical field, serving as a fundamental precursor for diverse glycoconjugates and glycans. By actively participating in the formation of cell surface receptors and extracellular matrix molecules, this product assumes a pivotal function in the intricate synthesis of nucleotide sugars and glycosylation processes. Its usability extends to studying drug-resistant epilepsy, neurodegenerative ailments and immunological disorders. Group: Pharmaceutical. Alternative Names: UDP-D-galactose disodium salt; UDP-α-D-Gal disodium salt; Uridine 5'-(trihydrogen diphosphate)? P'-α-D-galactopyranosyl ester disodium salt; UDP-galactose disodium salt. CAS No. 137868-52-1. Pack Sizes: 100 mg. Product ID: B2706-185823. Molecular formula: C15H22N2Na2O17P2. Mole weight: 610.27. Custom synthesis is available. Send your inquiries for more information. | London |
| Uridine 5'-Monophosphate Disodium Salt | Uridine 5'-Monophosphate Disodium Salt can be used in dietary supplement and RNA rich food. It may be beneficial for cognitive function. Nutritional supplement in health care products. Uses: Ingredient of health care products. Group: Pharmaceutical. Alternative Names: Uridine Monophosphate Disodium; 5'-Uridylic Acid Disodium Salt; Disodium 5'-uridylate; Disodium UMP; UMP sodium salt; Sodium UMP. CAS No. 3387-36-8. Pack Sizes: 100 g. Product ID: B2001-351347. Molecular formula: C9H11N2Na2O9P. Mole weight: 368.15. Custom synthesis is available. Send your inquiries for more information. | London |
| Uridine 5-oxyacetic acid | Uridine 5-oxyacetic acid, a biomedical marvel, holds immense promise for combating diverse neurological disorders and cognitive impairments. Functioning as a pivotal precursor for RNA synthesis, it evokes a remarkable enhancement in synaptic plasticity. Its potential therapeutic efficacy extends to esteemed conditions like Alzheimer's disease, Parkinson's disease, and the melancholy memory decline associated with aging. Group: Pharmaceutical. Alternative Names: Uridin-5-yloxyacetic acid; 5-(Carboxymethoxy)uridine; 5-Oxyacetyluridine; Acetic acid, ((1,2,3,4-tetrahydro-2,4-dioxo-1-beta-D-ribofuranosyl-5-pyrimidinyl)oxy)-; 2-((1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)oxy)acetic acid. CAS No. 28144-25-4. Pack Sizes: 5 mg. Product ID: B1370-340096. Molecular formula: C11H14N2O9. Mole weight: 318.24. Custom synthesis is available. Send your inquiries for more information. | London |
| Uridine 5-oxyacetic acid methyl ester | It is an anticancer agent. Group: Pharmaceutical. Alternative Names: Acetic acid, [(1,2,3,4-tetrahydro-2,4-dioxo-1-b-D-ribofuranosyl-5-pyrimidinyl)oxy]-, methyl ester; Methyl uridin-5-yloxyacetate; 5-(2-Methoxy-2-oxoethoxy)uridine; Methyluridine-5-oxyacetic acid; 5-Methoxycarbonylmethoxyuridine; Methyl 2-((1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)oxy)acetate. CAS No. 66536-81-0. Pack Sizes: 1 mg. Product ID: B1370-340234. Molecular formula: C12H16N2O9. Mole weight: 332.26. Custom synthesis is available. Send your inquiries for more information. | London |
| Urolithin A | Urolithin A is a secondary metabolite of ellagitannins by the gut bacteria. It exhibits anti-inflammatory, antioxidant and antiproliferative effects. Urolithin A can cross the blood brain barrier thus has the potential therapeutic effect against Alzheimer's Disease. Group: Pharmaceutical. Alternative Names: 3,8-dihydroxy-6H-benzo[c]chromen-6-one; 3,8-Dihydroxy-6H-dibenzo(b,d)pyran-6-one; 6H-Dibenzo[b,d]pyran-6-one, 3,8-dihydroxy-. CAS No. 1143-70-0. Pack Sizes: 1 g. Product ID: BBF-04125. Molecular formula: C13H8O4. Mole weight: 228.2. Custom synthesis is available. Send your inquiries for more information. | London |
| Urolithin C | Urolithin C is a chebulic ellagitannins metabolite with antioxidant activity. Group: Pharmaceutical. Alternative Names: 6H-Dibenzo[b,d]pyran-6-one, 3,8,9-trihydroxy-. CAS No. 165393-06-6. Pack Sizes: 100 mg. Product ID: B2703-010553. Molecular formula: C13H8O5. Mole weight: 244.2. Custom synthesis is available. Send your inquiries for more information. | London |
| Ursocholic acid | Ursocholic acid plays a role as a human urinary metabolite and a 7alpha-hydroxysteroid dehydrogenase inhibitor. Uses: Ursodeoxycholic acid (u850000) impurity. Group: Pharmaceutical. Alternative Names: 7-Epicholic acid; 3alpha,7beta,12alpha-Trihydroxy-5beta-cholanic acid; 3a,7b,12a-Trihydroxycholanate; (3α,5β,7β,12α)-3,7,12-Trihydroxycholan-24-oic Acid; Ursodeoxycholic Acid EP Impurity D. CAS No. 2955-27-3. Pack Sizes: 100 mg. Product ID: B1370-264335. Molecular formula: C24H40O5. Mole weight: 408.57. Custom synthesis is available. Send your inquiries for more information. | London |
| Ursodeoxycholic Acid | Ursodeoxycholic acid (UDCS) is a cell protectant used extensively to mitigate hepatic and biliary diseases. Ursodeoxycholic acid may be used to study its specific activities that range from reduction of cholesterol absorpition, cholesterol gallstone dissolution to suppression of immune response.IC50: M1-family aminopeptidase: IC50=2.6 μM (Plasmodium falciparum 3D7); NTCP: IC50=3.6 μM (human); HCT-116: IC50=>50 μM (human); GBM: IC50=>50 μM (human) Asbt: Ki=75 μM (human). Uses: Gallstone-dissolving drugs; anti-neoplastic; for the prevention and treatment of cholesterol gallstones; reduces hydrophobic bile acids and decreases both lymphocyte reactivity and serum alkaline phosphatase levels,ic50: m1-family aminopeptidase: ic50=2.6 μm (plasmodium falciparum 3d7); ntcp: ic50=3.6 μm (human); hct-116: ic50=>50 μm (human); gbm: ic50=>50 μm (human) asbt: ki= 75 μm (human). Group: Pharmaceutical. Alternative Names: 5beta-cholanic acid-3alpha,7beta-diol; Actigall; ursodeoxycholate; ursodiol; Ursodeoxycholic acid. CAS No. 128-13-2. Pack Sizes: 100 g. Product ID: NP6089. Molecular formula: C24H40O4. Mole weight: 392.57. Custom synthesis is available. Send your inquiries for more information. | London |
| Ursolic acid | Ursolic acid is a natural pentacyclic triterpenoid carboxylic acid displaying antitumor activity. It was shown to downregulate the MMP-2 and uPA expression, and also inhibit Na+/K+-ATPase activity (IC50 = 24.7 μM) as well as NF-κB activation in various cancer cell lines. Ursolic acid can induce apoptosis in cancer cells. Ursolic acid also has obvious antioxidant function, so it is widely used as a raw material for medicine and cosmetics. Uses: Antidepressant. Group: Pharmaceutical. Alternative Names: NSC-167406; NSC-4060; NSC167406; NSC4060; NSC 167406; NSC 4060; Malol; Prunol; Urson; 3beta-Hydroxyurs-12-en-28-oic acid. CAS No. 77-52-1. Pack Sizes: 25 g. Product ID: NP6978. Molecular formula: C30H48O3. Mole weight: 456.711. Custom synthesis is available. Send your inquiries for more information. | London |
| Usaramine | Usaramine is a pyrrolizidine alkaloid found in the seeds of Crolatalaria pallida. Uses: Antiseptic. Group: Pharmaceutical. Alternative Names: NISTC15503874; (15E)-12,18-Dihydroxysenecionan-11,16-dione; Mucronatine; (15E)-Retrorsine; trans-Retrorsine; Usaramin. CAS No. 15503-87-4. Pack Sizes: 20 mg. Product ID: B2703-417711. Molecular formula: C18H25NO6. Mole weight: 351.4. Custom synthesis is available. Send your inquiries for more information. | London |
| Ustusol A | Ustusol A is produced by the strain of Aspergillus ustus. Group: Pharmaceutical. Alternative Names: (3S,5S,9R,10S)-3,9,11-trihydroxydrim-7-en-6-one; 3β,9α,11-trihydroxy-6-oxodrim-7-ene; 1(4H)-Naphthalenone, 4a,5,6,7,8,8a-hexahydro-4,7-dihydroxy-4-(hydroxymethyl)-3,4a,8,8-tetramethyl-, (4R,4aS,7S,8aS)-. CAS No. 1175543-02-8. Pack Sizes: 1 mg. Product ID: BBF-04371. Molecular formula: C15H24O4. Mole weight: 268.35. Custom synthesis is available. Send your inquiries for more information. | London |
| Ustusolate A | Ustusolate A is produced by Aspergillus ustus and exerts weak cytotoxicity against HL-60 and A549 cells with IC50 values of 20.6 and 30.0 microM, respectively. Group: Pharmaceutical. Alternative Names: 6-O-(octa-2E,4E,6E-trienoyl)-12-hydroxy-6-epi-albrassitriol; 2,4,6-Octatrienoic acid, (1R,4S,4aS,8aS)-1,4,4a,5,6,7,8,8a-octahydro-4-hydroxy-3,4-bis(hydroxymethyl)-4a,8,8-trimethyl-1-naphthalenyl ester, (2E,4E,6E)-. CAS No. 1136611-58-9. Pack Sizes: 1 mg. Product ID: BBF-04365. Molecular formula: C23H34O5. Mole weight: 390.51. Custom synthesis is available. Send your inquiries for more information. | London |
| Ustusolate C | Ustusolate C is produced by Aspergillus ustus. Study shows that it has moderate cytotoxicity against A549 and HL-60 cells. Group: Pharmaceutical. Alternative Names: 9α-hydroxy-6β-(7-hydroxyocta-2E,4E-dienoyloxy)-5α-drim-7-en-11,12-olide; 2,4-Octadienoic acid, 7-hydroxy-, (5R,5aS,9aS,9bS)-1,3,5,5a,6,7,8,9,9a,9b-decahydro-9b-hydroxy-6,6,9a-trimethyl-1-oxonaphtho[1,2-c]furan-5-yl ester, (2E,4E)-. CAS No. 1188398-15-3. Pack Sizes: 1 mg. Product ID: BBF-04366. Molecular formula: C23H32O6. Mole weight: 404.5. Custom synthesis is available. Send your inquiries for more information. | London |
| Ustusolate E | Ustusolate E is a metabolite of marine-derived fungus Aspergillus ustus 094102. Ustusolate E exhibits cytotoxic activity against A549 and HL-60 cell lines. Group: Pharmaceutical. Alternative Names: 9α-hydroxy-6β-(6-oxohex-2E,4E-dienoyloxy)-5α-drim-7-en-11,12-olide; 2,4-Hexadienoic acid, 6-oxo-, (5R,5aS,9aS,9S)-1,3,5,5a,6,7,8,9,9a,9b-decahydro-9b-hydroxy-6,6,9a-trimethyl-1-oxonaphtho[1,2-c]furan-5-yl ester, (2E,4E)-. CAS No. 1175543-06-2. Pack Sizes: 1 mg. Product ID: BBF-04372. Molecular formula: C21H26O6. Mole weight: 374.43. Custom synthesis is available. Send your inquiries for more information. | London |
| Uzarigenin digitaloside | Uzarigenin digitaloside is a natural steroid found in the herbs of Nerium oleander. Group: Pharmaceutical. Alternative Names: 3beta-[(6-Deoxy-3-O-methyl-beta-D-galactopyranosyl)oxy]-14-hydroxy-5alpha,14beta-card-20(22)-enolide. CAS No. 61217-80-9. Pack Sizes: 1 mg. Product ID: NP6044. Molecular formula: C30H46O8. Mole weight: 534.69. Custom synthesis is available. Send your inquiries for more information. | London |
| Vabicaserin hydrochloride | Vabicaserin is a 5-HT2C receptor agonist and 5-HT2B receptor antagonist. It has the potential to treat Schizophrenia. Group: Pharmaceutical. Alternative Names: Vabicaserin HCl; SCA 136; SCA-136; SCA136. CAS No. 887258-94-8. Pack Sizes: 25 mg. Product ID: B0084-002015. Molecular formula: C15H21ClN2. Mole weight: 264.79. Custom synthesis is available. Send your inquiries for more information. | London |
| Vaccarin | Vaccarin is a major flavonoid glycoside in Vaccariae semen, and is expected to be useful in the treatment of vascular diseases. Uses: Anti-early pregnancy. Group: Pharmaceutical. Alternative Names: 6-(2-O-alpha-L-Arabinopyranosyl-beta-D-glucopyranosyl)-2-[4-(beta-D-glucopyranosyloxy)phenyl]-5,7-dihydroxy-4H-1-benzopyran-4-one. CAS No. 53452-16-7. Pack Sizes: 25 mg. Product ID: B2703-464480. Molecular formula: C32H38O19. Mole weight: 726.64. Custom synthesis is available. Send your inquiries for more information. | London |
| Vaccarin E | Vaccarin E is a compound of the flavonoid class isolated from the Semen Vaccariae. Group: Pharmaceutical. CAS No. 2252345-81-4. Pack Sizes: 5 mg. Product ID: B0005-053818. Molecular formula: C42H48O22. Mole weight: 904.82. Custom synthesis is available. Send your inquiries for more information. | London |
| Vacquinol-1 | Vacquinol-1, also known as NSC 13316, is an activator of MKK4-dependent macropinocytotic cell death in glioblastoma cells. In glioblastoma cells, Vacquinol-1 targets macropinocytosis, a cellular process that will not lead to cell death in normal cells. Group: Pharmaceutical. Alternative Names: Vacquinol 1; Vacquinol1; NSC 13316; NSC-13316; NSC13316. CAS No. 5428-80-8. Pack Sizes: 25 mg. Product ID: B1370-172394. Molecular formula: C21H21ClN2O. Mole weight: 352.86. Custom synthesis is available. Send your inquiries for more information. | London |
| Vadadustat | Vadadustat is a potent HIF (Hypoxia-inducible factor) inhibitor. It is under development for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. Group: Pharmaceutical. Alternative Names: AKB-6548; AKB 6548; AKB6548; PG-1016548. CAS No. 1000025-07-9. Pack Sizes: 50 mg. Product ID: B2693-338766. Molecular formula: C14H11ClN2O4. Mole weight: 306.7. Custom synthesis is available. Send your inquiries for more information. | London |
| VAL-083 | VAL-083 is a bi-functional alkylating agent that inhibits U251 and SF188 cell growth in monolayer better than TMZ and caused apoptosis. Group: Pharmaceutical. Alternative Names: Dianhydrodulcitol; Dulcitol diepoxide. CAS No. 23261-20-3. Pack Sizes: 100 mg. Product ID: B2693-000173. Molecular formula: C6H10O4. Mole weight: 146.14. Custom synthesis is available. Send your inquiries for more information. | London |
| Valaciclovir EP Impurity C | An impurity of Valacyclovir, an antiviral drug used for the treatment of herpes virus infections. Group: Pharmaceutical. Alternative Names: L-Valine, N-methyl-, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]ethyl ester; (S)-2-((2-Imino-6-oxo-2,3-dihydro-1H-purin-9(6H)-yl)methoxy)ethyl 3-methyl-2-(methylamino)butanoate; Acyclovir N-Methyl-L-valinate; 2-((2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy)ethyl N-methyl-L-valinate; N-Methyl Valacyclovir. CAS No. 1346747-65-6. Pack Sizes: 5 mg. Product ID: B0093-466136. Molecular formula: C14H22N6O4. Mole weight: 338.36. Custom synthesis is available. Send your inquiries for more information. | London |
| Valacyclovir Related Compound D | An impurity of Valacyclovir, an antiviral drug used for the treatment of herpes virus infections. Group: Pharmaceutical. Alternative Names: Valaciclovir USP RC D; N-Ethyl Valacyclovir ; 2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl-N-ethyl-L-valinate. CAS No. 1346747-69-0. Pack Sizes: 1 g. Product ID: B2694-466130. Molecular formula: C15H15N5O4. Mole weight: 352.39. Custom synthesis is available. Send your inquiries for more information. | London |
| Valbenazine | Valbenazine is a potent and highly selective vesicular monoamine transporter 2(VMAT2) inhibitor. It is a prodrug of the (+)-α isomer of tetrabenazine for tardive syndrome therapy. It is effective in regulating the levels of dopamine release during nerve communication, while at the same time having minimal impact on the other monoamines. It significantly improved tardive dyskinesia and was well tolerated in patients. It is an experimental drug being investigated for use in the treatment of tardive dyskinesia and Tourette syndrome. It was developed by Neurocrine Biosciences. Uses: Valbenazine is an experimental drug being investigated for use in the treatment of tardive dyskinesia and tourette syndrome. Group: Pharmaceutical. Alternative Names: Ingrezza; L-Valine, (2R,3R,11bR)-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo(a)quinolizin-2-yl ester; (S)-2-amino-3-methyl-butyric acid (2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-yl ester; Tetrabenazine Related Impurity 28 (2R, 3R, 11bR, L-Val); [(2R,3R,11bR)-9,10-dimethoxy-3-(2-methylpropyl)-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-yl] (2S)-2-amino-3-methylbutanoate; NBI-98854; NBI98854; MT-5199; MT5199; NBI 98854; MT 5199. CAS No. 1025504-45-3. Pack Sizes: 10 mg. Product ID: B0084-474971. Molecular formula: C24H38N2O4. Mole weight: 418.57. Custom synthesis is available. Send your inquiries for more in | London |
| Val-Cit-PAB-MMAE | Val-Cit-PAB-MMAE, a tubulin polymerase inhibitor, is a drug-linker conjugate for ADC. It contains an ADC linker (peptide Val-Cit-PAB) and a potent tubulin inhibitor MMAE. Group: Pharmaceutical. Alternative Names: L-Valyl-N-{4-[(5S,8S,11S,12R)-11-[(2S)-2-butanyl]-12-(2-{(2S)-2-[(1R,2R)-3-{[(1S,2R)-1-hydroxy-1-phenyl-2-propanyl]amino}-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl}-2-oxoethyl)-5,8-diisopropyl-4,10-dimethyl-3,6,9-trioxo-2,13-dioxa-4,7,10-triazatetradec-1-yl]phenyl}-N5-carbamoyl-L-ornithinamide. CAS No. 644981-35-1. Pack Sizes: 100 mg. Product ID: BBF-05881. Molecular formula: C58H94N10O12. Mole weight: 1123.43. Custom synthesis is available. Send your inquiries for more information. | London |
| Val-cit-PAB-OH | Val-cit-PAB-OH is a protease cleavable linker used in the synthesis of antibody-drug conjugates (ADCs). Group: Pharmaceutical. Alternative Names: L-valyl-N5-carbamoyl-N-[4-(hydroxymethyl)phenyl]-L-omithinamide; Val-cit-PAB; (S)-2-((S)-2-amino-3-methylbutanamido)-N-(4-(hydroxymethyl)phenyl)-5-ureidopentanamide. CAS No. 159857-79-1. Pack Sizes: 100 mg. Product ID: BADC-00708. Molecular formula: C18H29N5O4. Mole weight: 379.46. Custom synthesis is available. Send your inquiries for more information. | London |
| Valdecoxib Impurity B | Valdecoxib Impurity B is a dimeric impurity of Valdecoxib. Group: Pharmaceutical. Alternative Names: Valdecoxib Dimer; N-[4-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonyl]-4-(5-methyl-3-phenyl-4-isoxazolyl)benzenesulfonamide. CAS No. 1373038-60-8. Pack Sizes: 20 mg. Product ID: B2694-484465. Molecular formula: C32H25N3O6S2. Mole weight: 611.7. Custom synthesis is available. Send your inquiries for more information. | London |
| Valdecoxib Impurity E | An impurity of Valdecoxib. Valdecoxib is a non-steroidal anti-inflammatory drug (NSAID) used for the treatment of osteoarthritis, rheumatoid arthritis, etc. Valdecoxib exhibits a selectively inhibitory effect of cyclooxygenase-2. Group: Pharmaceutical. Alternative Names: Valdecoxib IMpurity-E; 3-(4-(4-(Chlorosulfonyl)phenyl)-5-methylisoxazol-3-yl)benzenesulfonyl chloride; 3-[4-(4-chlorosulfonylphenyl)-5-methyl-1,2-oxazol-3-yl]benzenesulfonyl chloride; 3-(4-(4-(Chlorosulfonyl)phenyl)-5-methylisoxazol-3-yl)benzene-1-sulfonyl chloride; YEC03863; 3-[4-[4-(Chlorosulfonyl)phenyl]-5-methyl-3-isoxazolyl]benzenesulfonyl chloride; 1-?Tert-?butyl 4-?ethyl 1H-?pyrazole-?1,?4-?dicarboxylate. CAS No. 1373038-63-1. Pack Sizes: 5 mg. Product ID: B2694-484468. Molecular formula: C16H11Cl2NO5S2. Mole weight: 432.3. Custom synthesis is available. Send your inquiries for more information. | London |
| Valdecoxib Impurity I | An impurity of Valdecoxib. Valdecoxib is a non-steroidal anti-inflammatory drug (NSAID) used for the treatment of osteoarthritis, rheumatoid arthritis, etc. Valdecoxib exhibits a selectively inhibitory effect of cyclooxygenase-2. Group: Pharmaceutical. Alternative Names: 3-(5-methyl-4-(4-sulfamoylphenyl)isoxazol-3-yl)benzenesulfonamide; AKOS030530317; ZINC200584589; BC600176; 3-(3-Aminosulfonylphenyl)-4-(4-aminosulfonylphenyl)-5-methylisoxazole. CAS No. 1373038-59-5. Pack Sizes: 5 mg. Product ID: B2694-484471. Molecular formula: C16H15N3O5S2. Mole weight: 393.44. Custom synthesis is available. Send your inquiries for more information. | London |
| Valganciclovir HCl | Valganciclovir hydrochloride hydrate is an antiviral used to treat cytomegalovirus infection. It is the prodrug of ganciclovir, a synthetic analog of 2'-deoxy-guanosine which is phosphorylated to a dGTP analog that competitively inhibits the incorporation of dGTP by viral DNA polymerase. Group: Pharmaceutical. Alternative Names: RS 079070-194; Ro 107-9070/194; Valcyte; (S)-Valganciclovir Hydrochloride. CAS No. 175865-59-5. Pack Sizes: 2.5 g. Product ID: B0084-061144. Molecular formula: C14H23ClN6O5. Mole weight: 390.82. Custom synthesis is available. Send your inquiries for more information. | London |
| Val-glu-pro-ile-pro-tyr | Val-glu-pro-ile-pro-tyr. Group: Pharmaceutical. Alternative Names: Valyl-glutamyl-prolyl-isoleucyl-prolyl-tyrosine; Vepipy; H-Val-Glu-Pro-Ile-Pro-Tyr-OH. CAS No. 94773-24-7. Pack Sizes: 50 mg. Product ID: B2699-071053. Molecular formula: C35H52N6O10. Mole weight: 716.82. Custom synthesis is available. Send your inquiries for more information. | London |
| Validamycin B | Validamycin B is an impurity of Validamycin that is resistant to rice sheath blight disease and Pellicularia sasakii. Group: Pharmaceutical. Alternative Names: Antibiotic T-7545-B; Val-B; (1R,2R,3S,4S,5R,6S)-2,3,5-trihydroxy-6-(hydroxymethyl)-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexyl beta-D-glucopyranoside; 1,5-Dideoxy-4-O-β-D-glucopyranosyl-5-(hydroxymethyl)-1-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-D-chiro-inositol. CAS No. 102583-47-1. Pack Sizes: 1mg;1g;10g. Product ID: BBF-03434. Molecular formula: C20H35NO14. Mole weight: 513.49. Custom synthesis is available. Send your inquiries for more information. | London |
| Validamycin C | An impurity of Validamycin. Validamycin is an antibiotic and fungicide. Group: Pharmaceutical. Alternative Names: BRN 4835203; (3-{[4-(hexopyranosyloxy)-2,3-dihydroxy-5-(hydroxymethyl)cyclohexyl]amino}-4,5,6-trihydroxycyclohex-1-en-1-yl)methyl hexopyranoside; 2-(hydroxymethyl)-6-[[3-[[5-(hydroxymethyl)-4-[6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-2,3-bis(oxidanyl)cyclohexyl]amino]-4,5,6-tris(oxidanyl)cyclohexen-1-yl]methoxy]oxane-3,4,5-triol. CAS No. 12650-70-3. Pack Sizes: 1mg;1g;10g. Product ID: BBF-03435. Molecular formula: C26H45NO18. Mole weight: 659.63. Custom synthesis is available. Send your inquiries for more information. | London |
| Valpromide | Valpromide is an antiepileptic drug, derivative of Valproic acid, used as a mood-stabilizer in bipolar disorder. Valpromide is also used as an augmentation strategy in refractory depression. Group: Pharmaceutical. Alternative Names: Depamide; Dipropylacetamide. CAS No. 2430-27-5. Pack Sizes: 1mg;1g;10g. Product ID: 2430-27-5. Molecular formula: C8H17NO. Mole weight: 143.23. Custom synthesis is available. Send your inquiries for more information. | London |
| Valrocemide | Valrocemide, also known as TV1901 or VGD, is a promising antiepileptic drug candidate with a broad spectrum of anticonvulsant activity. VGD is active in mice against maximal electroshock (MES)- and pentylenetetrazole- (Metrazol, Met) induced seizures and in rats against MES seizures. Group: Pharmaceutical. Alternative Names: N-(2-amino-2-oxoethyl)-2-propylpentanamide; N-valproyl glycinamide; N-valproylglycinamide; TV 1901; TV-1901; Valrocemide; VPGD cpd; TV1901. CAS No. 92262-58-3. Pack Sizes: 1mg;1g;10g. Product ID: 92262-58-3. Molecular formula: C10H20N2O2. Mole weight: 200.28. Custom synthesis is available. Send your inquiries for more information. | London |
| Valrubicin | Valrubicin (AD-32) is a chemotherapy drug used to treat bladder cancer. It is a semisynthetic analog of the anthracycline doxorubicin, and is administered by infusion directly into the bladder. Uses: Antineoplastic. Group: Pharmaceutical. Alternative Names: Pentanoic Acid 2-[(2S,4S)-1,2,3,4,6,11-Hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-[[2,3,6-trideoxy-3-[(2,2,2-trifluoroacetyl)amino]-α-L-lyxo-hexopyranosyl]oxy]-2-naphthacenyl]-2-oxoethyl Ester; Antibiotic AD 32; N-Trifluoroacetyladriamycin 14-Valerate; NSC 246131; Valstar; Valtaxin; 2-Oxo-2-[(2S,4S)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-({2,3,6-trideoxy-3-[(trifluoroacetyl)amino]-α-L-lyxo-hexopyranosyl}oxy)-1,2,3,4,6,11-hexahydro-2-tetracenyl]ethyl valerate. CAS No. 56124-62-0. Pack Sizes: 5 mg. Product ID: B0084-182305. Molecular formula: C34H36F3NO13. Mole weight: 723.64. Custom synthesis is available. Send your inquiries for more information. | London |
| Valsartan | Valsartan is a selective angiotensin II receptor antagonist, used to treat high blood pressure and congestive heart failure. Uses: Angiotensin ii type 1 receptor blockers; antihypertensive agents. Group: Pharmaceutical. Alternative Names: CGP48933, CGP-48933, CGP 48933, Valsartan, Diovan, Miten, Nisis, Prova, Tareg, Vals, Walsartan. CAS No. 137862-53-4. Pack Sizes: 1 g. Product ID: NP2632. Molecular formula: C24H29N5O3. Mole weight: 435.52. Custom synthesis is available. Send your inquiries for more information. | London |
| Valsartan benzyl ester | An intermediate of Valsartan. Valsartan is an antagonist of angiotensin II receptor mainly used for the treatment of high blood pressure and congestive heart failure. Group: Pharmaceutical. Alternative Names: Valsartan Impurity B; Benzyl (2S)-3-methyl-2-[pentanoyl[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]amino]butanoate; Valsartan Related Compound C; N-(1-Oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine phenylmethyl ester; USP Valsartan Related Compound C; Valsartan USP Related Compound C; (S)-Benzyl 2-(N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoate; L-Valine, N-(1-oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, phenylmethyl ester; Benzyl N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-N-pentanoyl-L-valinate; N-Valeryl-N-{[2'-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl}-L-valine benzyl ester; Valsartan EP Impurity B. CAS No. 137863-20-8. Pack Sizes: 25 mg. Product ID: B2694-394752. Molecular formula: C31H35N5O3. Mole weight: 525.66. Custom synthesis is available. Send your inquiries for more information. | London |
| Valsartan Cyano Analog Methyl Ester | An impurity of Valsartan. Valsartan is an antagonist of angiotensin II receptor mainly used for the treatment of high blood pressure and congestive heart failure. Group: Pharmaceutical. Alternative Names: N-[(2'-Cyano[1,1'-biphenyl]-4-YL)methyl]-N-(1-oxopentyl)-L-valine methyl ester; (S)-methyl2-(N-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoate; [N-(2-Cyanobiphenyl-4-yl)methyl]n-valery-(l)-valine methyl ester. CAS No. 137863-90-2. Pack Sizes: 50 mg. Product ID: B1370-049293. Molecular formula: C25H30N2O3. Mole weight: 406.52. Custom synthesis is available. Send your inquiries for more information. | London |
| Valsartan Desvaleryl Impurity | An impurity of Valsartan. Valsartan is an antagonist of angiotensin II receptor mainly used for the treatment of high blood pressure and congestive heart failure. Group: Pharmaceutical. Alternative Names: Des(oxopentyl) Valsartan; N-[[2'-(2H-Tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine; N-[[2'-(1H-Tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine. CAS No. 676129-92-3. Pack Sizes: 25 mg. Product ID: B2694-484484. Molecular formula: C19H21N5O2. Mole weight: 351.41. Custom synthesis is available. Send your inquiries for more information. | London |
| Valsartan EP Impurity C | An impurity in the synthesis of Valsartan. Valsartan is an antagonist of angiotensin II receptor mainly used for the treatment of high blood pressure and congestive heart failure. Group: Pharmaceutical. Alternative Names: Despentanoyl butanoyl valsartan; Valsartan Impurity C; (2S)-2-[Butanoyl[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]amino]-3-methylbutanoic acid; (S)-2-(N-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)butyramido)-3-methylbutanoic acid; Despentanoyl butanoyl valsartan; Valsartan USP Related Compound B; USP Valsartan Related Compound B; Valsartan Related Compound B; N-(1-Oxobutyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine; (S)-N-Butyryl-N-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]valine; Valsartan n-Propyl; Valsartan n-Propyl Impurity; N-Butyryl-N-{[2'-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl}-L-valine. CAS No. 952652-79-8. Pack Sizes: 25 mg. Product ID: B0179-407673. Molecular formula: C23H27N5O3. Mole weight: 421.49. Custom synthesis is available. Send your inquiries for more information. | London |
| Valsartan Ethyl Ester | An impurity of Valsartan. Valsartan is an antagonist of angiotensin II receptor mainly used for the treatment of high blood pressure and congestive heart failure. Group: Pharmaceutical. Alternative Names: N-(1-Oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine Ethyl Ester. CAS No. 1111177-30-0. Pack Sizes: 100 mg. Product ID: B1370-484486. Molecular formula: C26H33N5O3. Mole weight: 463.58. Custom synthesis is available. Send your inquiries for more information. | London |
Would you like to list your products on UK Chemical Suppliers?
Our database is helping our users find suppliers everyday.